Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
What’s wrong with IP rights? Protecting medicines from competition can be costly
NewsGram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...
Read more about What’s wrong with IP rights? Protecting medicines from competition can be costly
-
Activists file post-grant opposition challenging a patent preventing purchase of cheaper treatment for hepatitis C
NewsGTPI has presented an argument to the Brazilian Patent Office (INPI) to invalidate the patent granted for the drug daclatasvir....
-
Kularb’s story: Optimal treatment would reduce HIV-related stigma
InterviewInterview by Gemma Taylor. “I was told I’d have to wait for 10 more people to die before I could...
Read more about Kularb’s story: Optimal treatment would reduce HIV-related stigma
-
Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
NewsThe All-Ukrainian Network of People Living with HIV/AIDS (the Network) has received an official letter from Merck, dated 15 March...
Read more about Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
-
Watching Brazil: In defence of democracy and human rights
OpinionAuthor: Andresa Porto – Political Scientist and member of GTPI. Now that the Brazilian government’s new party blocs have been...
Read more about Watching Brazil: In defence of democracy and human rights
-
Watching Brazil. New monthly column analyzing the impact of Bolsonaro’s politics on civil society and access to medicines
OpinionAuthor: Andresa Porto – Political Scientist and member of GTPI.Translated from Portuguese, original version here. This is the first of...
-
Action against AbbVie. Money that could treat HIV patients ‘goes up in smoke’ in Kiev
Call to action NewsActivists gathered outside a Kiev Court to highlight the huge amount of money being wasted on an overpriced drug, due...
-
Looking back to build on our success. Making more medicines affordable in 2019
NewsWe’re gearing up for the next, expanded phase of our campaign. We’re determined that pharmaceutical companies and governments must #TreatPeopleRight...
Read more about Looking back to build on our success. Making more medicines affordable in 2019
-
Know your HIV status, know your treatment options, and demand optimal ARVs!
Interview NewsThe theme of the 30th World AIDS Day (1 December 2018) is ‘Know your status!’. It’s a shout out for...
Read more about Know your HIV status, know your treatment options, and demand optimal ARVs!
-
Dr Amit Sengupta, a treatment activist who dedicated his life to universal access, dies age 60
NewsWe are deeply saddened by the loss of Dr Amit Sengupta, our friend, colleague, and an inspiring treatment activist who...